BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Personalized medicine
,
Aspirin
,
rs3825942
,
VEGFA
,
Pseudomonas infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PAK 1
Summary
General Info
Curated Studies
Most Correlated Studies
Neuroblastoma cell line SH-SY5Y treated with thapsigargin, tunicamycin, or atrazine
Fibrocystic disease of breast MCF10AT cells with shRNA-mediated knockdown of EP300
Mitochondrial DNA depletion-related changes in gene expression in 143B TK- osteosarcoma cells
Influence of CFTR on derived dendritic cells infected with P. aeruginosa
Mammary gland MCF10A cells overexpressing wildtype MYC or non-phosphomimetic MYC mutants
Explore Curated Studies Results
Literature
Most Relevant Literature
Development and Utility of a PAK1-Selective Degrader.
p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.
p21-Activated kinases as promising therapeutic targets in hematological malignancies.
PAK1 and PAK2 in cell metabolism regulation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)
Personalized Information Before and After Total Knee Arthroplasty: PAK-study
Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ